Non Serious Adverse Drug Reactions Report

Start Date:2016-06-21 End Date:2016-06-22
Study :EMR200136_583Investigator :NACountry of Investigator :RomaniaSiteNo:005
Subject No :005-0001Subject Initials :DOB :08/27/1996Sex:FemaleRace:CaucasianHeight:169(cm)Weight:65(kg)
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Visit 5 (Month12)/Early Termination
Visit 1/ Baseline (Day 1)02/12/20155
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
local erythema and induration local site injection04/28/2015SuspectedMild
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Drug withdrawnLed to study terminationOngoing
Event description:
Subject received concomitant medications
Name of medicationStart DateOngoingEnd DateDoseUnitFrequency
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



22-JUN-16
NA/EMR200136_583/005-0001
Page 1 of 7
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-06-21 End Date:2016-06-22
Study :EMR200136_583Investigator :NACountry of Investigator :RomaniaSiteNo:005
Subject No :005-0009Subject Initials :DOB :04/22/1992Sex:FemaleRace:CaucasianHeight:173(cm)Weight:63(kg)
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Visit 5 (Month12)/Early Termination
Visit 1/ Baseline (Day 1)03/26/20159
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
local erythema, pain, ecchymosis06/09/2015SuspectedMild
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Drug withdrawnLed to study terminationOngoing
Event description:
Subject received concomitant medications
Name of medicationStart DateOngoingEnd DateDoseUnitFrequency
Does the subject have any relevant past or present medical conditions:No
ConditionStart DateRelated to study conditionOngoing



22-JUN-16
NA/EMR200136_583/005-0009
Page 2 of 7